President and Chief Scientific Officer
African Institute of Biomedical Science and Technology
Collen Masimirembwa is a pioneer in the research field of anti-HIV drugs with an award winning innovative Genetic Test and Dosing Algorithm for the identification of patients at high risk of neuropsychiatric adverse effects to anti-HIV drugs. He is a highly cited researcher with a career that stretches from Principal Scientist at AstraZeneca to currently President and Chief Scientific Officer at the African Institute of Biomedical Science and Technology. Join this talk filled with the insights of a life changing career!